pitressin 20 pu/ml solution for injection
mercury pharmaceuticals ltd - argipressin - solution for injection - 20 unit(s)/millilitre - vasopressin and analogues; argipressin
jinarc
otsuka pharmaceutical netherlands b.v. - tolvaptan - polycystic kidney, autosomal dominant - diuretics, - jinarc is indicated to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (adpkd) in adults with ckd stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease.
samsca
otsuka pharmaceutical netherlands b.v. - tolvaptan - inappropriate adh syndrome - diuretics, - treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion (siadh).,
tolvaptan accord
accord healthcare s.l.u. - tolvaptan - inappropriate adh syndrome - diuretics, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).
cpressin -p amp inj
samarth life - vasopressin - inj - 10u/ml - amp
cpressin -u 1ml pfs inj
samarth life - vasopressin - inj - 40u. - 1ml pfs
cpressin-p -u 1ml inj
samarth life - vasopressin - inj - 20u. - 1ml
petresin 20 amp
sg ph. - vasopressin - amp - 20u. - 20
neo-lidocaton
*** company unknown *** - lidocaine hydrochloride monohydrate 20mg; noradrenaline 0.02mg; vasopressin 0.25 [iu] - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 20mg noradrenaline 0.02mg vasopressin 0.25 [iu]
desmospray, desmopressin nasal spray
ferring ireland ltd - desmopressin acetate - nasal spray, solution - 10 microgram(s) - vasopressin and analogues; desmopressin